Related Experiment Video

Updated: Aug 17, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

[The relationship between carotid artery atherosclerosis and hyperhomocysteinaemia]

Hong-li Wang1, Dong-sheng Fan, Yang Shen

  • 1Department of Neurology, the Third Hospital, Peking University, Beijing 100083, China.

Zhonghua Nei Ke Za Zhi
|June 1, 2005
PubMed

Insights

Elevated homocysteine (Hcy) levels are linked to increased carotid artery atherosclerosis (CAA) severity. Lower folate and vitamin B12 may contribute to higher Hcy, suggesting potential for vitamin-based vascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Chemistry
  • Nutritional Science

Context:

  • Carotid artery atherosclerosis (CAA) is a significant risk factor for stroke.
  • Homocysteine (Hcy) has been implicated in vascular disease, but its precise role in CAA requires further elucidation.
  • The influence of B vitamins (folate, B12) and lipid profiles on CAA progression is not fully understood.

Purpose:

  • To investigate the association between carotid artery atherosclerosis (CAA) and serum levels of homocysteine (Hcy), folate, vitamin B12, and lipids.
  • To determine if Hcy is an independent risk factor for CAA and its severity.
  • To explore the relationship between B vitamin levels and Hcy concentration in subjects with varying degrees of CAA.

Summary:

  • A study of 126 subjects found a positive correlation between increased carotid artery atherosclerosis (CAA) severity and higher serum homocysteine (Hcy) levels.
  • Serum Hcy, total cholesterol (TC), and high-density lipoprotein (HDL) were identified as significant factors correlated with CAA severity.
  • Lower levels of folate and vitamin B12 were associated with elevated Hcy concentrations, suggesting a potential link to CAA development.

Impact:

  • This research identifies hyperhomocysteinemia as an independent risk factor for CAA, highlighting the clinical significance of Hcy levels.
  • Findings suggest that monitoring Hcy, TC, and HDL may aid in assessing CAA risk and severity.
  • The study supports the need for clinical trials to evaluate the efficacy of folate and vitamin B12 supplementation in preventing and managing vascular diseases.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...